Gerami D Seitzman

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Gerami D Seitzman, Jeremy D Keenan, Thomas M Lietman, Kevin Ruder, Lina Zhong, Cindi Chen, YuHeng Liu, Danny Yu, Thomas Abraham, Armin Hinterwirth, Thuy Doan, null null
Human Conjunctival Transcriptome in Acanthamoeba Keratitis: An Exploratory Study. Cornea (2024)
Gerami D Seitzman, Jeremy D Keenan, Thomas M Lietman, Kevin Ruder, Lina Zhong, Cindi Chen, YuHeng Liu, Danny Yu, Thomas Abraham, Armin Hinterwirth, Thuy Doan, null null
Human Conjunctival Transcriptome in Acanthamoeba Keratitis: An Exploratory Study. Cornea (2024)
Gerami D Seitzman, Jeremy D Keenan, Thomas M Lietman, Kevin Ruder, Lina Zhong, Cindi Chen, YuHeng Liu, Danny Yu, Thomas Abraham, Armin Hinterwirth, Thuy Doan, null null
Human Conjunctival Transcriptome in Acanthamoeba Keratitis: An Exploratory Study. Cornea (2024)
Gerami D Seitzman, Jeremy D Keenan, Thomas M Lietman, Kevin Ruder, Lina Zhong, Cindi Chen, YuHeng Liu, Danny Yu, Thomas Abraham, Armin Hinterwirth, Thuy Doan, null null
Human Conjunctival Transcriptome in Acanthamoeba Keratitis: An Exploratory Study. Cornea 43 (10) (2024)
Meenu Chaudhary, Sanjeeta Sitaula, Kevin Ruder, Cindi Chen, Lina Zhong, Yu Heng Lu, Thomas Abraham, Danny Yu, Armin Hinterwirth, Thomas M Lietman, Thuy Doan, Gerami D Seitzman, null null
Heterogenous pathogen profile associated with acute conjunctivitis in Nepal. International health (2023)
Hamidah Mahmud, Jeremy D Keenan, John Gonzales, Julie Schallhorn, Matilda Chan, Benjamin Arnold, Victoria Cavallino, Thomas M Lietman, Thuy Doan, Gerami D Seitzman
Ocular Rosacea microBiome Study (ORBS)-sub-microbial versus antibiotic dosing of doxycycline versus placebo in treatment of symptomatic ocular rosacea: study protocol for a parallel-arm randomized clinical trial. Trials 23 (1) (2022)
Arman Mosenia, Anh H Nguyen, Mark R Mandel, Gerami D Seitzman
Nocardia sienata : a new causative species of infectious keratitis. BMJ case reports 15 (3) (2022)
Hamidah Mahmud, Jeremy D Keenan, John Gonzales, Julie Schallhorn, Matilda Chan, Benjamin Arnold, Victoria Cavallino, Thomas M Lietman, Thuy Doan, Gerami D Seitzman
Ocular Rosacea microBiome Study (ORBS)-sub-microbial versus antibiotic dosing of doxycycline versus placebo in treatment of symptomatic ocular rosacea: study protocol for a parallel-arm randomized clinical trial. Trials 23 (1) (2022)
Caitlin A Moe, Prajna Lalitha, N Venkatesh Prajna, Jeena Mascarenhas, Muthiah Srinivasan, Manoranhan Das, Arun Panigrahi, Revathi Rajaraman, Gerami D Seitzman, Catherine E Oldenburg, Thomas M Lietman, Jeremy David Keenan
Outcomes of amoebic, fungal, and bacterial keratitis: A retrospective cohort study. PloS one 17 (2) (2022)
Hamidah Mahmud, Jeremy D Keenan, John Gonzales, Julie Schallhorn, Matilda Chan, Benjamin Arnold, Victoria Cavallino, Thomas M Lietman, Thuy Doan, Gerami D Seitzman
Ocular Rosacea microBiome Study (ORBS)-sub-microbial versus antibiotic dosing of doxycycline versus placebo in treatment of symptomatic ocular rosacea: study protocol for a parallel-arm randomized clinical trial. Trials 23 (1) (2022)
Michael S Deiner, Gerami D Seitzman, Gurbani Kaur, Stephen D McLeod, James Chodosh, Thomas M Lietman, Travis C Porco
Sustained Reductions in Online Search Interest for Communicable Eye and Other Conditions During the COVID-19 Pandemic: Infodemiology Study. JMIR infodemiology 2 (1) (2022)
Gurbani Kaur, Travis K Redd, Gerami D Seitzman
Practice Patterns and Clinician Opinions for Treatment of Ocular Rosacea. Cornea (2022)

Gerami D Seitzman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gerami D Seitzman